Exchange: NASDAQ·Updated 09:53 AM EST
CGEN logo

CGEN Compugen Ltd

$2.09
$0.00
(0.00%)
Today
Reported EarningsNov 9
Mkt Cap$197.98M
Vol17,519.00

About CGEN

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
46

Neutral Sentiment

How do you feel about CGEN?

Advertisement|Remove ads.